Efficacy of a glucose meter connected to a mobile app on glycemic control and adherence to self-care tasks in patients with T1DM and LADA: a parallel-group, open-label, clinical treatment trial

التفاصيل البيبلوغرافية
العنوان: Efficacy of a glucose meter connected to a mobile app on glycemic control and adherence to self-care tasks in patients with T1DM and LADA: a parallel-group, open-label, clinical treatment trial
المؤلفون: Felipe Martins de Oliveira, Luís Eduardo Procópio Calliari, Cecília Kauffman Rutenberg Feder, Maria Fernanda Ozorio de Almeida, Mariana Vilela Pereira, Maria Thereza Teixeira de Almeida Fagundes Alves, Sônia Aparecida Dias Garcia, Ligia Dinara Donizeti Reis, João Eduardo Nunes Salles
المصدر: Archives of Endocrinology and Metabolism v.65 n.2 2021
Arquivos de Endocrinologia e Metabolismo
Sociedade Brasileira de Endocrinologia e Metabologia (SBEM)
instacron:SBEM
Archives of Endocrinology and Metabolism, Issue: ahead, Published: 05 MAR 2021
Archives of Endocrinology and Metabolism, Volume: 65, Issue: 2, Pages: 185-197, Published: 05 MAR 2021
Archives of Endocrinology and Metabolism, Vol 65, Iss 2, Pp 185-197 (2021)
بيانات النشر: Archives of Endocrinology and Metabolism, 2021.
سنة النشر: 2021
مصطلحات موضوعية: Adult, Blood Glucose, self-management, medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, Glycemic Control, Diseases of the endocrine glands. Clinical endocrinology, Carbohydrate counting, chemistry.chemical_compound, Insulin Infusion Systems, Internal medicine, Diabetes mellitus, medicine, Humans, Hypoglycemic Agents, Insulin, blood glucose, Glycemic, Glycated Hemoglobin, Type 1 diabetes, business.industry, Standard treatment, Glucose meter, Diabetes mellitus, type 1, RC648-665, medicine.disease, Mobile Applications, Self Care, Regimen, Diabetes Mellitus, Type 1, chemistry, glycated hemoglobin A, Medicine, treatment adherence and compliance, Glycated hemoglobin, business
الوصف: Objective: The main aim of the study was to evaluate the patients’ glycemic control and adherence to self-care tasks. Materials and methods: Patients with type 1 diabetes mellitus (T1DM) or latent autoimmune diabetes of the adult (LADA) using a multiple daily injection (MDI) regimen with carbohydrate counting (n = 25, Subgroup B) or fixed insulin dose (n = 25, Subgroup C) were allocated to use the application (app) for 12 weeks. Both subgroups were compared with each other and against a control group (n = 25, Group A) comprising patients with T1DM or LADA treated with continuous subcutaneous insulin infusion (CSII) in a parallel-group, open-label, clinical treatment trial. All patients had glycated hemoglobin (A1C) levels measured and were asked to fill out the Diabetes Self-Management Profile (DSMP) questionnaire at study start and end. The patients were instructed to measure capillary glucose six times daily in study weeks 4, 8, and 12. Results: Mean A1C levels decreased 0.725% in Subgroup C in intragroup analysis (p = 0.0063), and had a mean variation of 0.834% compared with Group A (p = 0.003). Mean DSMP scores increased 5.77 points in Subgroup B in intragroup analysis (p = 0.0004) and increased by a mean of 6.815 points in relation to Group A (p = 0.002). Conclusion: OneTouch Reveal improved both A1C levels and DSMP scores in patients with T1DM or LADA compared with standard treatment (CSII).
وصف الملف: text/html
تدمد: 2359-4292
2359-3997
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe7fac7b2e40a1ff9fbb2e507b649a83Test
https://doi.org/10.20945/2359-3997000000334Test
حقوق: OPEN
رقم الانضمام: edsair.doi.dedup.....fe7fac7b2e40a1ff9fbb2e507b649a83
قاعدة البيانات: OpenAIRE